Meropenem and piperacillin-tazobactam levels for critical care patients during empiric therapy

Ann Acad Med Singap. 2021 May;50(5):447-449. doi: 10.47102/annals-acadmedsg.2020472.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Critical Care*
  • Humans
  • Meropenem / therapeutic use
  • Microbial Sensitivity Tests
  • Penicillanic Acid
  • Piperacillin*
  • Piperacillin, Tazobactam Drug Combination

Substances

  • Anti-Bacterial Agents
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Meropenem
  • Piperacillin